These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31704171)

  • 1. Charting a TRP to Novel Therapeutic Destinations for Kidney Diseases.
    Pablo JL; Greka A
    Trends Pharmacol Sci; 2019 Dec; 40(12):911-918. PubMed ID: 31704171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRPC Channels in Proteinuric Kidney Diseases.
    Hall G; Wang L; Spurney RF
    Cells; 2019 Dec; 9(1):. PubMed ID: 31877991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal TRPathies.
    Dietrich A; Chubanov V; Gudermann T
    J Am Soc Nephrol; 2010 May; 21(5):736-44. PubMed ID: 20395377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRP channels in kidney disease.
    Hsu YJ; Hoenderop JG; Bindels RJ
    Biochim Biophys Acta; 2007 Aug; 1772(8):928-36. PubMed ID: 17346947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRP channels as therapeutic targets in kidney disease and hypertension.
    Menè P; Punzo G; Pirozzi N
    Curr Top Med Chem; 2013; 13(3):386-97. PubMed ID: 23432067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRPC6 and FSGS: the latest TRP channelopathy.
    Mukerji N; Damodaran TV; Winn MP
    Biochim Biophys Acta; 2007 Aug; 1772(8):859-68. PubMed ID: 17459670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A small-molecule inhibitor of TRPC5 ion channels suppresses progressive kidney disease in animal models.
    Zhou Y; Castonguay P; Sidhom EH; Clark AR; Dvela-Levitt M; Kim S; Sieber J; Wieder N; Jung JY; Andreeva S; Reichardt J; Dubois F; Hoffmann SC; Basgen JM; Montesinos MS; Weins A; Johnson AC; Lander ES; Garrett MR; Hopkins CR; Greka A
    Science; 2017 Dec; 358(6368):1332-1336. PubMed ID: 29217578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The small GTPase regulatory protein Rac1 drives podocyte injury independent of cationic channel protein TRPC5.
    Polat OK; Isaeva E; Sudhini YR; Knott B; Zhu K; Noben M; Suresh Kumar V; Endlich N; Mangos S; Reddy TV; Samelko B; Wei C; Altintas MM; Dryer SE; Sever S; Staruschenko A; Reiser J
    Kidney Int; 2023 Jun; 103(6):1056-1062. PubMed ID: 36750145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryo-EM structure of the cytoplasmic domain of murine transient receptor potential cation channel subfamily C member 6 (TRPC6).
    Azumaya CM; Sierra-Valdez F; Cordero-Morales JF; Nakagawa T
    J Biol Chem; 2018 Jun; 293(26):10381-10391. PubMed ID: 29752403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
    Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
    Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of transient receptor potential channels in kidney disease.
    Woudenberg-Vrenken TE; Bindels RJ; Hoenderop JG
    Nat Rev Nephrol; 2009 Aug; 5(8):441-9. PubMed ID: 19546862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRPC channels: Regulation, dysregulation and contributions to chronic kidney disease.
    Dryer SE; Roshanravan H; Kim EY
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1041-1066. PubMed ID: 30953689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
    Ilatovskaya DV; Staruschenko A
    Am J Physiol Renal Physiol; 2015 Sep; 309(5):F393-7. PubMed ID: 26084930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balancing calcium signals through TRPC5 and TRPC6 in podocytes.
    Greka A; Mundel P
    J Am Soc Nephrol; 2011 Nov; 22(11):1969-80. PubMed ID: 21980113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRPC6 in glomerular health and disease: what we know and what we believe.
    Schlöndorff JS; Pollak MR
    Semin Cell Dev Biol; 2006 Dec; 17(6):667-74. PubMed ID: 17116414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ion channels and channelopathies in glomeruli.
    Staruschenko A; Ma R; Palygin O; Dryer SE
    Physiol Rev; 2023 Jan; 103(1):787-854. PubMed ID: 36007181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological inhibition of focal segmental glomerulosclerosis-related, gain of function mutants of TRPC6 channels by semi-synthetic derivatives of larixol.
    Urban N; Neuser S; Hentschel A; Köhling S; Rademann J; Schaefer M
    Br J Pharmacol; 2017 Nov; 174(22):4099-4122. PubMed ID: 28800680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury.
    Verheijden KAT; Sonneveld R; Bakker-van Bebber M; Wetzels JFM; van der Vlag J; Nijenhuis T
    J Am Soc Nephrol; 2018 Aug; 29(8):2099-2109. PubMed ID: 29954830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of AC1903 analogs as potent transient receptor potential canonical channel 4/5 inhibitors and biological evaluation.
    Chen L; Zhang Z; Tian H; Jiang S; Ji Y; Liu M; Shen J; Cao Z; Wang K
    Bioorg Med Chem; 2022 Aug; 68():116853. PubMed ID: 35653869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural mechanism of human TRPC3 and TRPC6 channel regulation by their intracellular calcium-binding sites.
    Guo W; Tang Q; Wei M; Kang Y; Wu JX; Chen L
    Neuron; 2022 Mar; 110(6):1023-1035.e5. PubMed ID: 35051376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.